Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

40 results about "Molecular hybridization" patented technology

Molecular hybridization in molecular biology, formation of a partially or wholly complementary nucleic acid duplex by association of single strands, usually between DNA and RNA strands or previously unassociated DNA strands, but also between RNA strands; used to detect and isolate specific sequences, measure homology, or define other characteristics ...

Nucleic acid releasing agent suitable for rapid release of multiple samples and nucleic acid releasing method

PendingCN119020459Afast protein structureQuickly decipher protein structureMicrobiological testing/measurementSequence analysisActive agent
The invention discloses a nucleic acid releasing agent suitable for quick release of multiple samples and a nucleic acid releasing method. The nucleic acid releasing agent comprises guanidinium isothiocyanate with the concentration of 10 mM to 50 mM, ammonium sulfate with the concentration of 20 mM to 200 mM, a metal ion chelating agent with the concentration of 1 mM to 5 mM, a buffer solution with the concentration of 50 mM to 500 mM, a nonionic detergent with the volume percent of 0.1% to 10%, an anion active agent with the volume percent of 0.05% to 1% and a PCR (Polymerase Chain Reaction) enhancer with the volume percent of 0.05% to 5%. The nucleic acid releasing agent has the advantages that the nucleic acid releasing agent can rapidly crack protein structures of cells, viruses and the like, sample release can be completed within 1-3 min at the room temperature, the sample extraction time is greatly shortened, follow-up rapid detection is facilitated, the nucleic acid releasing agent can serve as a sample preservation solution, the protection effect on bacteria and viruses of oral cavity, blood and cervical exfoliated cells is achieved, and the nucleic acid releasing agent has a good application prospect. The nucleic acid release method disclosed by the invention has compatibility to multiple samples, and the released nucleic acid can be used for downstream experiments such as PCR (Polymerase Chain Reaction), cloning, sequence analysis, molecular hybridization and the like.
Owner:SHENZHEN DEXIA DIAGNOSTIC TECH CO LTD

Reaction vessel, molecular hybridization apparatus, application thereof, and detection method

ActiveUS12172165B2Microbiological testing/measurementBurettes/pipettesAnalyteMolecular hybridization
Provided is a reaction cup, comprising cup walls and a cup bottom. The cup walls are provided with clamping portions, the clamping portions can allow a membrane strip to stand upright in the reaction cup, and the connecting area of the two opposite clamping portions forms an upright placement position for the membrane strip. The present invention further provides a molecular hybridization instrument used with the reaction cup, and an analyte testing method. The reaction cup can allow the membrane strip to stand upright therein, and can be opened for operation, thereby reducing the area occupied by the reaction cup on the molecular hybridization instrument, and reducing the area of the molecular hybridization instrument. A plurality of reaction cups can be placed on the molecular hybridization instrument at the same time, which increases the number of tests and improves the utilization and working efficiency of the molecular hybridization instrument.
Owner:LEADWAY HK

Nicotinamide derivative with antifungal activity and containing (-)-menthol group as well as preparation method and application of nicotinamide derivative

The invention discloses a (-)-menthol group-containing nicotinamide derivative with antifungal activity as well as a preparation method and application thereof, and relates to the technical field of synthesis of agricultural chemicals. The derivative has a structure as shown in a general formula (I), in the formula, n is an integer from 1 to 5, and R1, R2, R3 and R4 are specific substituent groups. Through a molecular hybridization strategy, the (-)-menthol, the N-fatty acyl piperazine bridge and the nicotinamide fragment are covalently linked, and a compound with a brand new structure is created. A biological activity test shows that the series of compounds have remarkable inhibitory activity on various plant pathogenic fungi, especially sclerotinia sclerotiorum and valsa mali of apple trees, and are low in cytotoxicity. Molecular docking research proves that the action target of the gene is succinate dehydrogenase (SDH). The invention provides a valuable leading structure for developing novel SDHI bactericides.
Owner:HANSHAN NORMAL UNIV +1

A cinnamic acid derivative, its preparation method and application

This invention belongs to the field of pharmaceutical technology related to the treatment of acute liver injury (AILI), specifically relating to a cinnamic acid derivative, its preparation method, and its applications. Based on a fragment-linked molecular hybridization strategy, this invention selects phenylpropanoid natural acids with definite hepatoprotective activity as an anti-inflammatory lead scaffold. These compounds share a phenylpropionic acid core and can downregulate the expression of pro-inflammatory factors such as TNF-α and IL-6. Simultaneously, a phenothiazine scaffold with excellent antioxidant properties is introduced as a ferroptosis regulatory fragment, which can precisely combat the core driving force of lipid peroxidation by directly neutralizing free radicals and upregulating the endogenous antioxidant system. The two pharmacophores are covalently linked by ester bonds, aiming to construct a novel hybrid molecule with synergistic anti-inflammatory and antioxidant effects. The goal is to achieve simultaneous multi-target inhibition of inflammatory signals and the ferroptosis pathway in a single entity, thereby providing an innovative strategy for breaking the vicious cycle of AILI and developing highly effective and low-toxicity therapeutic lead compounds.
Owner:YANAN UNIV

Fully Automatic Nucleic Acid Molecular Hybridization Instrument (YH96pro)

ActiveCN309418279SMolecular hybridizationCell biology
1. Name of the Design Product: Automatic Nucleic Acid Hybridization Instrument (YH96pro). 2. Use of the Design Product: For automatic hybridization of nucleic acids. 3. Design Key Points of the Design Product: The combination of shape and pattern. 4. Picture or Photograph that Best Illustrates the Design Key Points: Perspective view.
Owner:JIANGXI YIJIAN MEDICAL EQUIP CO LTD

Molecular barcoding on opposite transcript ends

Disclosed herein include systems, methods, compositions, and kits for molecular barcoding on the 5'-end of a nucleic acid target. After barcoding a nucleic acid target using an oligonucleotide barcode comprising a target binding region and a molecular label to generate a barcoded nucleic acid molecule, an oligonucleotide comprising a complement of the target binding region can be added to generate a barcoded nucleic acid molecule comprising the target-binding region and the complement of the target-binding region. A stem loop is formed with intra-molecular hybridization of the barcoded nucleic acid molecule, which can be extended to generate an extended barcoded nucleic acid molecule comprising the molecular label and a complement of the molecular label.
Owner:BECTON DICKINSON & CO

Aspirin-sulfonamide hybrids, processes for their preparation and use

The application relates to the technical field of aspirin pharmaceutical chemistry, in particular to an aspirin-sulfonamide hybrid, a preparation method and application thereof. The preparation method can synthesize a plurality of novel aspirin-sulfonamide hybrids by taking piperazine as a bridge, and by a three-step continuous method of "acyl chlorination, sulfonamidation and N-acylation" according to a "molecular hybridization principle". In the process, only one separation and purification is performed, and the preparation steps are simple. The aspirin-sulfonamide hybrid prepared by the method is most effective on human non-small cell lung cancer cells A549, and the activity is more than 33 times higher than that of a parent aspirin, and is similar to the activity of an anticancer drug irinotecan. The aspirin-sulfonamide hybrid 3k prepared by the method has a certain inhibitory effect on various cancer cells. The hybrid can induce human non-small cell lung cancer A549 cell apoptosis in a concentration-dependent manner, and can induce human non-small cell lung cancer A549 cell cycle arrest in the G0 / G1 phase, and inhibit cell growth.
Owner:NINGXIA UNIVERSITY

A method for analyzing gene expression of plant-pathogen interaction based on umi tag

PendingCN122168738AMicrobiological testing/measurementExpression LibraryNucleotide
The present application relates to the field of biotechnology and molecular detection, in particular to a plant and pathogenic bacteria interaction gene expression analysis method based on UMI tag, comprising: obtaining interaction sample total nucleic acid extract; and constructing a molecular hybridization system with host-specific chimeric blocking probes containing locked nucleic acid modification and 3' end dideoxy modification, and reverse transcription primers; through temperature rising and denaturation and temperature reduction and annealing, the blocking probes are combined with host high abundance nucleic acid to form a hybridization blocking complex, and the primers are combined with pathogenic bacteria nucleic acid; template switching oligonucleotides with unique molecular identifier sequences and reverse transcriptase are added, the host extension is blocked, and UMI is introduced into the pathogenic bacteria complementary chain, and an interaction expression library is generated; after sequencing, the pathogenic bacteria effective reads and the host invalid reads are counted, and the effective interaction signal signal-to-noise ratio is output; the present application can preferentially capture pathogenic bacteria transcripts in the high background of host RNA.
Owner:GERMPLASM INNOVATION GRAND SCIENCE CENTER OF WESTERN CHINA (CHONGQING) SCIENCE CITY +1

Molecular hybridization instrument and operating device

The invention discloses a molecular hybridization instrument and an operation device, the operation device comprises a displacement mechanism, a liquid adding and discharging mechanism and an optical detection mechanism, and the liquid adding and discharging mechanism and the optical detection mechanism are both connected with the displacement mechanism; the shifting mechanism is used for shifting the liquid adding and discharging mechanism and the optical detection mechanism to each sample storage group along the arrangement direction of the sample storage groups in the sample box; the liquid adding and discharging mechanism is used for extracting waste liquid in each sample storage position at the same time when the sample storage group is moved, or injecting a reagent into each sample storage position at the same time; and the optical detection mechanism is used for performing optical detection on each sample storage position while moving to the sample storage group. According to the operation device, the detection efficiency can be greatly improved, meanwhile, due to the fact that liquid adding and discharging and detection are conducted through the liquid adding and discharging mechanism and the optical detection mechanism respectively, structures with different use functions operate independently and do not interfere with one another, the influence of frequent action of the liquid adding and discharging mechanism on the stability of the optical detection mechanism is reduced, and stable operation of the whole machine is guaranteed.
Owner:YANENG BIOSCIENCE (SHENZHEN) CO LTD

Gene detection platform based on micro-fluidic chip and thalassemia detection kit

The invention discloses a gene detection platform based on a micro-fluidic chip, which integrates an operation platform, the micro-fluidic chip, a control system, an automatic pipetting device and the like, and is characterized in that a plurality of independent detection channels are arranged on the micro-fluidic chip; each detection channel is provided with a PCR amplification chamber, an amplification product analysis chamber, a two-way pump, a waste liquid collection chamber, a three-way electromagnetic valve and the like, and the detection platform can realize full-automatic liquid preparation, nucleic acid extraction (whole blood mode, omitting the step), PCR amplification, denaturation, molecular hybridization and the like on the basis of the micro-fluidic chip. And the whole process of the steps of result storage, interpretation and the like is automatic, so that the integrated detection requirement of'sample feeding and result outputting 'is met. Meanwhile, the kit is applied to the detection of thalassemia genes, and specific primers and probes are designed and screened to obtain the thalassemia detection kit, and the kit has the advantages of being convenient to operate, high in detection precision, low in cost, visual in result interpretation and the like.
Owner:THE PEOPLES HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION

An antitumor pterostilbene piperazine conjugate, a preparation method and application thereof

The application belongs to the technical fields of synthesis of compounds and pharmaceutical applications, and discloses an anti-tumor pterostilbene piperazine conjugate as well as a preparation method and application thereof. The pterostilbene, piperazine and various substituents are spliced in one molecule by using a molecular hybridization method, a novel anti-tumor pterostilbene piperazine conjugate is synthesized, and it is found through anti-tumor activity research that the anti-tumor activity of the conjugate is obviously higher than that of the two pharmacophores alone, and the conjugate has the potential to become a novel anti-tumor drug. The pterostilbene piperazine conjugate is synthesized, and it is found for the first time that the compound has good anti-tumor activity, can significantly inhibit the proliferation of various tumor cells in vitro, including hepatocarcinoma, triple-negative breast cancer, colon cancer and ovarian cancer cells, has little toxicity to normal cells, and can inhibit the migration ability of tumor cells. Therefore, the compound synthesized by the application has good anti-tumor application prospect.
Owner:TIANJIN UNIV OF SCI & TECH

Preparation and application of a CD56 protein-specific nanobody-HRP fusion protein

The present invention relates to the field of biotechnology, and in particular to the preparation and application of a CD56 protein-specific nanoantibody-HRP fusion protein. The present application discloses a CD56 protein-specific nanoantibody-HRP fusion protein and a preparation method thereof, as well as the application of the fusion protein in preparing a product for detecting CD56 protein-specific antibodies in serum. The HRP-fused nanoantibody prepared in the present application constructs a fusion protein of a primary antibody and a labeled HRP through genetic engineering, converting two molecular hybridizations into one molecular hybridization, which can greatly shorten the duration of enzyme-linked immunosorbent assay and improve the accuracy. Compared with traditional antibodies, nanoantibodies are easier to genetically manipulate and can be coupled with a variety of labeled enzymes.
Owner:SHANDONG LIFEI BIOLOGICAL IND CO LTD

RNA-Editing Compositions and Methods of Use

Provided herein are engineered guides configured, upon hybridization to target RNA molecules, to form double stranded RNA substrates comprising (i) a region comprising at least one structural feature; and (ii) a first internal loop and a second internal loop, wherein the double stranded RNA substrates recruit RNA editing entities and facilitate chemical modifications of base nucleotides in the target RNA molecules. Also provided herein are compositions, vectors, and cells comprising the engineered guides disclosed herein. Also provided herein are methods of introducing the engineered guides described herein into cells and methods of treating a disease or condition in a subject in need thereof comprising administering to the subject the engineered guides, polynucleotides encoding the engineered guides, delivery vehicles comprising such engineered guides or such polynucleotides, or pharmaceutical compositions comprising any one of these as described herein.
Owner:SHAPE THERAPEUTICS INC

5alpha, 8alpha-peroxy ergosterol-quaternary ammonium salt derivative as well as preparation method and application thereof

The invention provides a 5alpha, 8alpha-peroxy ergosterol-quaternary ammonium salt derivative as well as a preparation method and application thereof, and belongs to the technical field of medicinal chemistry. The preparation method comprises the following steps: firstly, synthesizing a peroxy-ergosterol bromate derivative by taking 5alpha, 8alpha-peroxy-ergosterol as a raw material; then, based on the molecular hybridization theory, a series of side chains with different amino substituent groups are introduced to the peroxy ergosterol bromate derivative, and a quaternary ammonium salt structure is constructed. A series of 5 alpha, 8 alpha-peroxy ergosterol-quaternary ammonium salt derivatives with clinical anti-tumor application potential are designed and synthesized. An anti-tumor activity test shows that the obtained derivative has different degrees of inhibiting effects on tumor cells of human lung cancer, liver cancer, breast cancer and the like and shows a remarkable inhibiting effect on human breast cancer MDA-MB-231 cells, and the anti-tumor activity of the derivative with the most excellent activity is improved by 69 times compared with that of a lead compound 5alpha, 8alpha-peroxy ergosterol.
Owner:QIQIHAR MEDICAL UNIVERSITY

Solid-phase gene chip molecular hybridization instrument

The invention discloses a solid-phase gene chip molecular hybridization instrument which comprises a bottom plate, a heat cover, a swing driving assembly and a swing fulcrum assembly, and heating elements are arranged in the bottom plate and the heat cover; the control unit is used for controlling the temperature of the heating element and the swing driving assembly, the heating element emits heat at the same time, and the swing driving assembly drives the bottom plate, the heat cover and the molecular hybridization container to swing around the swing fulcrum assembly in a reciprocating mode at the same time. The molecular hybridization container has the advantages that on the premise that trace liquid does not lose, a variable-speed reciprocating motion field of the molecular hybridization container is constructed through a brand-new asymmetric swing mode with fluid mechanics gain, high-frequency shear force is induced on a solid-liquid interface, and diffusion limitation of the solid-liquid interface under a trace system is overcome; meanwhile, high-precision temperature control and anti-condensation effects are achieved through solid heat transfer on the upper side and the lower side, and the temperature non-uniformity and the fringe effect in traditional solid-phase hybridization are effectively solved.
Owner:SUZHOU LASSO BIOCHIP TECH CO LTD

Methods, compositions, and systems for barcoding and spatial analysis

The present disclosure relates in some aspects to methods, compositions, and kits of processing or analyzing a sample. A method for processing a sample may comprise providing probes with barcodes to generate a composite barcode, detecting the barcodes to determine a spatial location and hybridizing probes to analytes (e.g., an RNA molecule) and performing sequencing.
Owner:10X GENOMICS INC

Cyclopentene chromene-cinnamate compound as well as preparation method and application thereof

The invention provides a cyclopentene chromene-cinnamate compound as well as a preparation method and application thereof, and belongs to the technical field of organic synthesis. According to the invention, mangiferin is taken as a guide, and a cyclopentenochromene structure is designed and synthesized from cyclopentenopyrane and a chromene skeleton by using molecular hybridization and skeleton transition strategies. According to the cyclopentenochromene-cinnamate derivative containing the cinnamic acid active fragment, the cinnamic acid fragment with pesticide activity is grafted to the 8-site of cyclopentenochromene, the cyclopentenochromene-cinnamate derivative containing the cinnamic acid active fragment is synthesized, and the obtained compound has good insecticidal activity, bactericidal activity and plant virus resisting activity.
Owner:INSTITUTE OF APPLIED CHEMISTRY JIANGXI ACADEMY OF SCIENCES

A control method and system for nucleic acid molecule hybridization instrument program components

The invention provides a control method and system for a program component of a nucleic acid molecular hybridization instrument, and relates to the technical field of network applications. Firstly, a local program component of a nucleic acid molecular hybridization instrument is run to confirm the legitimacy of the program component, wherein the program component is composed of a plurality of self-defined segments, contains a command domain and a parameter domain, and is described in plain text for easy adjustment; then, the program component is parsed, an automatic process of nucleic acid molecular hybridization is encapsulated in the program component, the command domain of each segment of the program component is matched with a logic frame table of the nucleic acid molecular hybridization instrument, an instruction set of the nucleic acid molecular hybridization instrument is compiled and generated, and finally, the instructions in the instruction set are executed, and interaction is performed in a timely manner according to demand, the logic frame table is easy to understand, and the entire control process of the program component of the nucleic acid molecular hybridization instrument is easy to read and adjust, and the automatic control does not require programmers to adjust codes, and is suitable for use by on-site biotechnical technicians and experimenters who are not engaged in professional program work.
Owner:HYBRIBIO MEDTECH DEVICE CO LTD +2

Easily-installed elisa plate clamp for molecular hybridization furnace

ActiveCN222952361UMaterial analysisStructural engineeringMolecular hybridization
The utility model discloses an easy-to-install elisa plate clamp for a molecular hybridization furnace, and relates to the technical field of elisa plate clamps. The ELISA plate clamping device comprises a bottom plate and a clamping part which is movably arranged on the surface of the bottom plate and is used for clamping an ELISA plate, the clamping part comprises a bearing plate with a boss, a pair of limiting baffle rings arranged on the opposite sides and rubber blocks installed on the inner side walls of the limiting baffle rings. The boss is sleeved with a bottom shell of the elisa plate, a pair of opposite side edges of the bottom shell are located between the boss and the limiting baffle ring, and the side edges of the elisa plate are extruded through rubber blocks on the inner side wall of the limiting baffle ring and then clamped. The elisa plate clamping device can meet the requirement for clamping the elisa plates in various forms and sizes; and compared with an elastic sheet structure, the situation that hands are cut is avoided, and the leakage of built-in substances in a hybridization tube carried on the elisa plate can be avoided.
Owner:SHANGHAI HUXI IND CO LTD

A reusable spatial indexing template chip, replicable template chip, spatial transcriptome chip and preparation method and application thereof

The application discloses a reusable spatial index template chip, a replicable template chip, a spatial transcriptome chip and a preparation method and application thereof. A composite index library compatible with a general sequencing platform is designed, spatial barcode mapping is completed on a commercial chip to obtain a spatial index template chip. Through molecular hybridization and enzymatic extension technology, a known coordinate array is copied to a receptor chip, and multiple generations of copying are supported, so that a batch spatial transcriptome chip preparation system sharing the same spatial coordinate atlas is constructed. The application realizes deep compatibility with a standard sequencing platform through composite index library design, decouples a spatial capture carrier from an original sequencing chip, significantly reduces experimental starting cost, and provides a large-scale solution for high-throughput and low-cost spatial omics large-scale application.
Owner:ZHEJIANG UNIV

Catalytic nucleic acid system

PCT designated stageWO2025181497A1Microbiological testing/measurementPtru catalystMolecular hybridization
A complex for a toehold exchange system is provided. The complex comprised a substrate molecule and an output molecule. The substrate molecule and output molecule each comprise: a plurality of complementary regions where the substrate molecule and the output molecule are hybridised; and a non-complementary region where the substrate molecule and output molecule are not hybridised, the non-complementary region being located between complementary regions. The substrate molecule comprises a first exposed toehold region for hybridisation to a catalyst molecule and a second covered toehold region for hybridisation to a fuel molecule, and wherein the second covered toehold region comprises the region of non- complementarity. A toehold exchange system comprising the complex is also provided.
Owner:NANOVERY LTD

Compositions and methods for treating muscle atrophy and myotonic dystrophies

To provide compositions and methods for treating muscle atrophy and myotonic dystrophies.SOLUTION: This application discloses a polynucleic acid molecule conjugate comprising an antibody or binding fragment thereof conjugated to a polynucleic acid molecule that hybridizes to a target sequence of an atrogene, wherein the polynucleic acid molecule comprises at least one 2' modified nucleotide, at least one modified internucleotide linkage, or at least one inverted abasic moiety, and the polynucleic acid molecule conjugate mediates RNA interference against the atrogene, thereby treating muscle atrophy or myotonic dystrophy in a subject. In a certain embodiment, atrogene comprises atrogin-1 gene (FBXO32), MuRF1 gene (TRIA63), FOXO1, FOXO3, or MSTN.SELECTED DRAWING: Figure 19A
Owner:AVIDITY BIOSCI INC

mRNA complexes, their manufacturing, and their use for treatment

PCT designated stageWO2025227104A1Organic active ingredientsDNA/RNA fragmentationBiochemistryMolecular hybridization
Provided herein is an mRNA complex comprising an mRNA molecule and at least one engineered oligonucleotide hybridized to the mRNA molecule, wherein said engineered oligonucleotide is hereafter referred to as the Str-O-Nuc.
Owner:PARCEL BIOSCIENCES INC +2

Construction method for high-throughput sequencing library, kit, and use

Embodiments provide a construction method for a high-throughput sequencing library, a kit, and a use. The method comprises: using a Tn5 transposase complex to randomly break a DNA in a genome sample to obtain a DNA breakage product; carrying out molecular hybridization on an RNA enrichment probe and the DNA breakage product, and using streptavidin magnetic beads to collect an RNA-DNA complex in a molecular hybridization product; and carrying out methylation treatment and PCR amplification on the RNA-DNA complex to obtain a sequencing library. The method achieves directed enrichment of a target methylation site in the genome sample; when a new target methylation site needs to be added, an RNA enrichment probe is simply designed for same; when the target methylation site that has been proven to have a poor effect needs to be deleted, the RNA enrichment probe corresponding thereto is simply removed; and by means of the directed enrichment of the target methylation site, the concentration requirement of the genome sample is reduced, and trace detection is facilitated.
Owner:ZHENHE PHARM (HANGZHOU) CO LTD

mRNA complexes, their manufacturing, and their use for treatment

PCT designated stageWO2025227104A9Organic active ingredientsDNA/RNA fragmentationBiochemistryMolecular hybridization
Provided herein is an mRNA complex comprising an mRNA molecule and at least one engineered oligonucleotide hybridized to the mRNA molecule, wherein said engineered oligonucleotide is hereafter referred to as the Str-O-Nuc.
Owner:PARCEL BIOSCIENCES INC +2

mRNA complexes, their manufacturing, and their use for treatment

PCT designated stageWO2026090171A1Organic active ingredientsVector-based foreign material introductionBiochemistryMolecular hybridization
Provided herein is an mRNA complex comprising an mRNA molecule and at least one engineered oligonucleotide hybridized to the mRNA molecule, wherein said engineered oligonucleotide is hereafter referred to as the Str-O-Nuc.
Owner:PARCEL BIOSCIENCES INC +2

RNA editing compositions and methods of use

Provided herein are engineered guides configured to form a double-stranded RNA substrate upon hybridization to a target RNA molecule, the double-stranded RNA substrate comprising (i) a region comprising at least one structural feature, and (ii) a first internal loop and a second internal loop, which recruits an RNA editing entity and facilitates chemical modification of a base nucleotide in the target RNA molecule. Also provided herein are compositions, vectors, and cells comprising the engineered guides disclosed herein. Also provided herein are methods of introducing the engineered guides described herein into a cell, and methods of treating a disease or condition in a subject in need thereof, the methods comprising administering to a subject an engineered guide, a polynucleotide encoding the engineered guide, a delivery vehicle comprising such an engineered guide or such a polynucleotide, or a pharmaceutical composition comprising any one of these, as described herein.
Owner:SHAPE THERAPEUTICS INC

Molecular hybridization instrument and liquid path system

The invention discloses a molecular hybridization instrument and a liquid path system.The liquid path system comprises a plurality of reagent supply assemblies, a quantifying device, a liquid mixing container, a plurality of liquid injection pipelines, a gating device and a control module, and the control module is electrically connected with the quantifying device and the gating device; and the control module is used for controlling the gating device to selectively communicate the different reagent supply assemblies with the quantifying device according to the components of the preset mixed reagents, and controlling the quantifying device to obtain the reagents with different preset liquid amounts from the different reagent supply assemblies according to the components of different types of preset mixed reagents. According to the liquid path system, the quantitative device can be controlled according to the components of different types of preset mixed reagents to obtain the reagents with the preset liquid amount required by the components from different reagent supply assemblies, and compared with a manual liquid preparation mode in the related technology, the liquid path system has the advantages that liquid preparation can be accurate, and reagent waste is avoided. And moreover, the reagents are stored in the sealed reagent storage container, so that the problems of volatilization, even crystallization and deterioration caused by contact with air can be avoided.
Owner:YANENG BIOSCIENCE (SHENZHEN) CO LTD

Molecular hybridization instrument for optimizing reagent mixing treatment effect

The invention relates to the related technical field of molecular hybridization, and discloses a molecular hybridization instrument for optimizing reagent mixing treatment effect, which comprises a hybridization instrument body, a reaction cabin is arranged in the middle of the hybridization instrument body, a cabin door is rotatably arranged on one side of the reaction cabin, a control panel is arranged on one side of the outer part of the hybridization instrument body, and a mixing assembly is arranged in the reaction cabin; two first circular plates can be driven to rotate and move back and forth through rotation and back-and-forth movement of a circular tube, and the two first circular plates rotate and move back and forth to drive a plurality of hybridization tubes to rotate and move back and forth, so that the effect of uniformly mixing reagents in the hybridization tubes is improved; a plurality of second sliding plates, third push rods and arc-shaped plates move back and forth, so that a plurality of hybridization tubes shake back and forth in a plurality of grooves in the radial direction, and the effect of uniformly mixing reagents in the hybridization tubes is further improved.
Owner:HANGZHOU LINAN DISTRICT FIRST PEOPLES HOSPITAL (MEDICAL COMMUNITY OF HANGZHOU LINAN DISTRICT FIRST PEOPLES HOSPITAL)